Elanco Animal Health Cash Flow from Operating Activities 2016-2023 | ELAN

Elanco Animal Health annual/quarterly cash flow from operating activities history and growth rate from 2016 to 2023. Cash flow from operating activities can be defined as a company's cash flows from operations.
  • Elanco Animal Health cash flow from operating activities for the quarter ending December 31, 2023 was $0.271B, a 40.04% decline year-over-year.
  • Elanco Animal Health cash flow from operating activities for the twelve months ending December 31, 2023 was $156M, a 85.54% decline year-over-year.
  • Elanco Animal Health annual cash flow from operating activities for 2023 was $0.271B, a 40.04% decline from 2022.
  • Elanco Animal Health annual cash flow from operating activities for 2022 was $0.452B, a 6.42% decline from 2021.
  • Elanco Animal Health annual cash flow from operating activities for 2021 was $0.483B, a 1278.05% decline from 2020.
Elanco Animal Health Annual Cash Flow Ops
(Millions of US $)
2023 $271
2022 $452
2021 $483
2020 $-41
2019 $224
2018 $487
2017 $174
2016 $156
2015 $7
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.436B $4.417B
Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.436B 10.55
Quest Diagnostics (DGX) United States $15.460B 15.98
DaVita (DVA) United States $12.016B 14.93
Encompass Health (EHC) United States $8.745B 22.38
Chemed (CHE) United States $8.614B 26.70
Option Care Health (OPCH) United States $5.209B 19.72
RadNet (RDNT) United States $4.191B 87.28
Amedisys (AMED) United States $3.128B 22.16
LifeStance Health (LFST) United States $2.825B 0.00
Astrana Health (ASTH) United States $2.242B 30.32
Addus HomeCare (ADUS) United States $1.798B 25.73
U.S Physical Therapy (USPH) United States $1.603B 42.90
Pennant (PNTG) United States $0.667B 35.25
Aveanna Healthcare Holdings (AVAH) United States $0.494B 0.00
Atai Life Sciences (ATAI) Germany $0.320B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.027B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.014B 0.00
Novo Integrated Sciences (NVOS) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00